Carnegie acted as joint global coordinator and joint bookrunner in the directed share issues of 5,912,477 shares at a subscription price of SEK 160 per share. Cellink is a global life-science company developing and delivering life-science solutions for cell culturing. August 2020.
Healthcare
Directed share issue in CELLINK AB (SE) — SEK 946 million
August 2020